Inventor · disambiguated record
Ivona Jasprica
Also filed as: JASPRICA IVONA
9 granted patents·4 pending applications·37 citations·filing 2014–2024
86Inventor score
Top patents by PatentIndex Score
13 records- 0194US11517609B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2022·Granted Dec 6, 2022·3 cites·7 claims
- 0293US11000567B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2019·Granted May 11, 2021·5 cites·28 claims
- 0393US10039804B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2017·Granted Aug 7, 2018·14 cites·17 claims
- 0492US10188697B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2015·Granted Jan 29, 2019·11 cites·26 claims
- 0591US10849956B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2018·Granted Dec 1, 2020·3 cites·24 claims
- 0688US2025288640A1Glycopeptide compositionsHIKMA PHARMACEUTICALS USA INC·Filed 2024·Application pending·0 cites
- 0787US11628200B2Glycopeptide compositionsXELLIA PHARMACEUTICALS APS·Filed 2021·Granted Apr 18, 2023·1 cites·18 claims
- 0884US12161690B2Glycopeptide compositionsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Granted Dec 10, 2024·0 cites·19 claims
- 0965US2024139278A1Oxytocin formulationXELLIA PHARMACEUTICALS APS·Filed 2023·Application pending·0 cites
- 1063US11141417B2Voriconazole inclusion complexesXELLIA PHARMACEUTICALS APS·Filed 2019·Granted Oct 12, 2021·0 cites·19 claims
- 1150US10729708B2Stabilized glycopeptide antibiotic formulationsXELLIA PHARMACEUTICALS APS·Filed 2017·Granted Aug 4, 2020·0 cites·10 claims
- 1243US2022218784A1Daptomycin Aqueous FormulationsXELLIA PHARMACEUTICALS APS·Filed 2020·Application pending·0 cites
- 1340US2015352112A1Voriconazole inclusion complexesXELLIA PHARMACEUTICALS APS·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ivona Jasprica files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →